BMP-4 Genetic Variants and Protein Expression Are Associated with Platinum-Based Chemotherapy Response and Prognosis in NSCLC

Table 6

HR for prognosis of NSCLC patients undergoing chemotherapy.

Factors	HR^†	95% CI^†	𝑃^†
6007C > T
CC	1
TT	2.37	1.58–3.98	0.003
BMP-4 expression
Low	1
High	3.87	1.37–4.25	<0.001

†Adjusted with age, sex, smoke status, histology, stage, and chemotherapy agents.